Stock Groups

How the Cure for Herpes Became Mired in Controversy, the latest chapter in the battle between Big Pharma and Synergy Pharmaceuticals By BTC Peers

[ad_1]

The latest in the fight between Big Pharma, Synergy Pharmas and Synergy Pharmas is How the Cure for Herpes became mired in controversy

For many decades, FDA has worked hard to keep its relationships with pharmaceutical giants intact. Many of the approvals for prescription drugs like Isotretinoin and Pemoline were later recalled due to irreversible harm or patient death. And this dynamic hasn’t been limited to medical treatments. Although extensive research has shown that sugar is the most common cause of cardiovascular disease and diabetes in the United States, FDA still endorses it. This was because they fear that warning labels might have negative consequences for agriculture and food industry producers. Given these historical patterns, it comes as no surprise that the FDA is opposed to natural medicine, especially when alternative treatments threaten to cut into pharmaceutical companies’ market share.

Synergy Pharmaceuticals, one of these companies is currently under fire from the FDA. Given that the product catalog contains only natural vitamins, its name can be a little confusing. The name is shared by two other companies, making it even more confusing. Synergy Pharmaceuticals Australia went out of business in 2016 after Synergy Pharmaceuticals, New York. But the Australian company was still associated with controversy from its inception.

Synergy Pharmaceuticals Australia was forced to close temporarily in November 2020 due to COVID-19 supply chain problems. The company was able to resume operations after changing ownership in May 2021.

However, it’s Synergy’s most high-profile product that has generated controversy, not its most recent business troubles. The company bills itself as the producer of the world’s first cure for the herpes simplex virus. Unsurprisingly, this claim has drawn a lot of criticism and cynicism. But the degree to which the naysayers, the pharmaceutical industry, and conventional medicine practitioners have scrutinized Synergy’s treatment is nearly insurmountable. In any other scenario, one would consider such a development a monumental leap forward in herpes sufferers’ fight against the virus. Synergy Pharmaceuticals is now at the centre of an ugly battle led by traditional medicine advocates.

Their pushback is in opposition to the treatment’s proven success. In reviewing online feedback and forum discussions to date, there’s a contingent of patients who have clearly been cured and who can vouch for the treatment’s ability to eradicate the virus. Still, there are just as many who refute the treatment’s effectiveness. Those in the latter camp are mostly individuals who haven’t used the treatment but feel strongly that natural medicine is incapable of curing any virus. Opponents would trust only their physician or other medical professionals to verify a cure. Their resistance is naïve, as more than 40% of pharmaceutical drugs are derived from plants. Penicillium chloride, which is an essentially mold-like species, was used to create penicillin. You can make Morphine from opium poppy, or aspirin using willow bark. Many people don’t realize that natural and conventional medicine have much more in common with Synergy Pharmaceuticals.

To investigate, we compared the effectiveness of Synergy’s treatment to that of Acyclovir, the most commonly used suppressant medication for herpes patients. Acyclovir must be taken every day in order to control herpes and cold sores. This is the most striking difference. The medication didn’t provide a long-term solution unless it was administered regularly, and even then, it had only a modest rate of actually stopping outbreaks from occurring. By comparison, Synergy’s product reduced herpes outbreaks and cold sores permanently. In one independent study, those who’d suffered frequent outbreaks on a monthly or bimonthly basis went on to have no further outbreaks or just one or two outbreaks per year. The results of this study were taken after a six month clinical trial. These findings suggest that the treatment’s benefit remained intact for patients after the protocol was finished.

Furthermore, one only needs to assess the long list of Acyclovir side effects to determine whether it’s worth the financial outlay and health implications. Given that Synergy’s natural product has the potential for only a handful of mild side effects and costs far less, explaining the difference between the two products is like comparing apples to oranges.

From an external perspective, however, Synergy has clearly been unable to capitalize on its product’s ability to cure people of herpes due to what can only be described as poor marketing. When you consider that the FDA only allows advertising on medical centers and in mainstream media, this is quite understandable. It is a shame that people seeking genuine help cannot access the product due to the marketing restrictions and the monopoly on conventional medicine. To remedy this, Synergy conducted trials, and Yale University students also carried out an independent study, all designed to determine if Synergy’s product does what it claims to do. The product’s effectiveness was confirmed by both research methods. It cleared infected individuals of the herpes virus. The percentage rate certainly works in Synergy’s favor, with an estimated 70% of trial subjects cured of herpes, but even having just 30% of participants cured would have been miraculous – it’s something that has never been accomplished by any means, let alone a pharmaceutical-based medication.

A groundbreaking innovation like Synergy’s product, one that eases the suffering of herpes simplex virus patients, should be embraced, not shunned or chastised. It is clear that Synergy was not able to navigate the difficult road of implementing its invention. There is hope this product will be more mainstream over the next few years. This product will need to be expanded into Europe and may require more investment. Both aspects could bring Synergy’s vision to fruition, while also quieting some of the controversy and reducing the stigma associated with herpes.

Though, to date, the ultimate takeaway is that changing the status quo – especially when it comes to shifting the way the medical community views natural medicine – is no easy task.

Website: https://www.synergy-pharmaceuticals.com/

Continue reading on BTC Peers



[ad_2]